Pharmaron Beijing Co Ltd
Pharmaron Beijing's GHG Emissions Data Preview
In 2024, Pharmaron Beijing completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Pharmaron Beijing has also provided a category-level breakdown for 11 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Pharmaron Beijing's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Pharmaron Beijing amounted to 198,700.78 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Pharmaron Beijing decreased by 20.99%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Pharmaron Beijing's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Pharmaron Beijing's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Pharmaron Beijing were 34,268 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Pharmaron Beijing reduced its Scope 1 emissions over time?
Since 2020, Pharmaron Beijing's Scope 1 emissions have increased by 250.07%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Pharmaron Beijing's Scope 1 emissions decreased by 1.4%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Pharmaron Beijing's Scope 2 emissions?
In 2024, Pharmaron Beijing reported Scope 2 greenhouse gas (GHG) emissions of 164,432.78 tCOâ‚‚e using the market-based method.
Has Pharmaron Beijing reduced its Scope 2 emissions over time?
Compared to the previous year (2023), Pharmaron Beijing's Scope 2 emissions (Market-Based) fell by 24.13% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does Pharmaron Beijing use for Scope 2 reporting?
In 2024, Pharmaron Beijing reported its Scope 2 emissions using the market-based method.
Pharmaron Beijing's Scope 2 Emissions Over Time
- Total Scope 2 Market-Based
- Total Scope 2 (Unspecified Calculation Method)
Insights into Pharmaron Beijing's Value Chain Emissions
In 2024, Pharmaron Beijing reported 414,817.33 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of Pharmaron Beijing includes a breakdown across 11 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2023, reflecting improved emissions accounting practices and greater transparency across the company's value chain
Pharmaron Beijing's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Pharmaron Beijing's Scope 3 emissions?
In 2024, Pharmaron Beijing reported total Scope 3 emissions of 414,817.33 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 99.89% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.11% came from downstream activities like product use, distribution, and end-of-life treatment.
Compared to the previous year (2023), Pharmaron Beijing's Scope 3 emissions remained relatively stable, indicating that Pharmaron Beijing 's emissions have plateaued with no significant change in its value chain footprint.
What categories of Scope 3 emissions does Pharmaron Beijing disclose?
In 2024, Pharmaron Beijing reported emissions for 11 out of the 15 Scope 3 categories defined by the GHG Protocol.
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Pharmaron Beijing's Scope 3 emissions?
In 2024, the largest contributors to Pharmaron Beijing's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 227,403.06 tCOâ‚‚e (54.82%)
- Capital Goods (Cat. 2): 79,244.67 tCOâ‚‚e (19.1%)
- Fuel- and Energy-Related Services (Cat. 3): 57,102.51 tCOâ‚‚e (13.77%)
Pharmaron Beijing's Scope 3 Emissions by Categories
Insights into Pharmaron Beijing's Total Carbon Footprint
In 2024, Pharmaron Beijing reported a total carbon footprint of 613,518.11 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5.12% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to Pharmaron Beijing's total carbon footprint was Scope 3 emissions, accounting for 67.61% of the company's total carbon footprint, followed by Scope 2 emissions at 26.8%.